SBRA Stock Analysis: Buy, Sell, or Hold?
SBRA - Sabra Healthcare REIT, Inc.
$20.67
-0.53 (-2.50%)
▼
5d:
-0.39%
30d:
+0.05%
90d:
+2.48%
BUY
MODERATE Confidence
Analysis Updated: May 15, 2026 12:00 AM ET
Earnings: May 06, 2026
0d
Get Alerted When SBRA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: SBRA shows positive signals but monitor for confirmation. Market pricing in 1.9% growth. Moderate conviction.
💡 BUY OPPORTUNITY: SBRA shows positive signals but monitor for confirmation. Market pricing in 1.9% growth. Moderate conviction.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$26.68
Based on 7.0% avg growth
INTRINSIC VALUE TODAY
$16.57
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: SBRA is currently trading at $20.67, which is considered slightly high relative to its 30-day fair value range of $20.06 to $20.78. The stock's valuation (Forward PE: 27.2) is in line with its historical norms (25.7). At these levels, the market is pricing in 1.9% annual earnings growth.
Technical Outlook: Technically, SBRA is in a strong uptrend. The price is currently testing key support at $20.13. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: SBRA has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, SBRA is in a strong uptrend. The price is currently testing key support at $20.13. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: SBRA has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$20.06 -
$20.78
Company Quality Score
66/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
74.8%
All Signals
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($22.23)
- BULLISH: Expecting earnings turnaround to 1.9% growth with 21.7% revenue growth
Trading Range Analysis
30-Day Trading Range
$20.06 -
$20.78
Current vs Trading Range
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$20.13
Resistance Level
$21.28
Current Trend
Strong Uptrend
Technical data as of
May 15, 2026
Fundamental Context
Forward P/E (Next Year Est.)
27.20
Wall Street Target
$22.23
(+7.6%)
Revenue Growth (YoY)
21.7%
Earnings Growth (YoY)
-5.6%
Profit Margin
19.1%
Valuation Premium vs History
+1.9% premium
PE vs Historical
27.2 vs 25.7
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+1.9%
(market-implied from PE analysis)
1-Year Target
$21.06
(+2%)
2-Year Target
$21.46
(+4%)
3-Year Target
$21.87
(+6%)
3-Yr Target (if PE normalizes)
(PE: 27→26)
PE COMPRESSION
$20.67
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 27.2, Growth: 10.1%)
$27.62
(+34%)
Base:
(SPY PE: 22.1, Growth: 10.1%)
$22.41
(+8%)
Bear:
(PE: 18.8, Growth: 10.1%)
$19.05
(-8%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (34x PE), but valuation improves significantly next year (27x PE) as earnings recover.
Trailing PE: 33.65 | Current EPS (TTM): $0.63
Bull Case
$28.13
(+36%)
Analyst growth 20.6%, PE expands to 37.0
Base Case
$25.57
(+24%)
Market implied 20.6%, PE stable at 33.7
Bear Case
$14.42
(-30%)
Severe decline -20.0%, PE contracts to 28.6
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: May 16, 2026 9:02 AM ET
Data refreshes hourly during market hours. Next update: 10:02 AM
Data refreshes hourly during market hours. Next update: 10:02 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SBRA showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated REIT - Healthcare Facilities Stocks
Top-rated stocks in REIT - Healthcare Facilities by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
VTR
Ventas Inc |
STRONG BUY
20 analysts |
$95 | 65 BUY |
|
WELL
Welltower Inc |
STRONG BUY
20 analysts |
$233 | 60 BUY |
|
DOC
Healthpeak Properties Inc |
STRONG BUY
20 analysts |
$20 | 59 HOLD |
|
STRW
Strawberry Fields REIT L… |
STRONG BUY
7 analysts |
$15 | 62 BUY |
|
AHR
American Healthcare REIT… |
STRONG BUY
9 analysts |
$58 | 62 BUY |
